Literature DB >> 19431196

Significance of promoter hypermethylation of p16 gene for margin assessment in carcinoma tongue.

Parul Sinha1, S Bahadur, Alok Thakar, Ajay Matta, Muzafar Macha, Ranju Ralhan, S Datta Gupta.   

Abstract

BACKGROUND: Loss of p16 expression by promoter hypermethylation has been reported as an early event in the development of oral cancer. The aim of our study was to explore the prognostic implications of presence of promoter hypermethylation of p16 gene in surgical margins in carcinoma tongue.
METHODS: A prospective analysis of 38 patients with resectable carcinoma tongue was carried out. DNA from tumor and the surgical margins was assessed by methylation-specific polymerase chain reaction. Follow-up duration was 17 to 37 months.
RESULTS: About 86.8% of tumors showed promoter hypermethylation of p16 gene. Out of 30 patients with histologically free margins, 43.3% showed positivity on molecular assessment. Patients with positive molecular margins had a 6.3-fold increased risk of having local recurrence as compared to patients with negative margins.
CONCLUSION: Promoter hypermethylation of p16 gene may serve as a useful molecular marker for predicting local recurrence in carcinoma tongue. (c) 2009 Wiley Periodicals, Inc. Head Neck, 2009.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19431196     DOI: 10.1002/hed.21122

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  15 in total

1.  Promoter hypermethylation in Indian primary oral squamous cell carcinoma.

Authors:  Jatinder Kaur; Semra Demokan; Satyendra Chandra Tripathi; Muzafar Ahmad Macha; Shahnaz Begum; Joseph A Califano; Ranju Ralhan
Journal:  Int J Cancer       Date:  2010-11-15       Impact factor: 7.396

Review 2.  Epigenetic mechanisms in oral carcinogenesis.

Authors:  Jacqueline A Gasche; Ajay Goel
Journal:  Future Oncol       Date:  2012-11       Impact factor: 3.404

Review 3.  Molecular margins in head and neck cancer: Current techniques and future directions.

Authors:  Katelyn O Stepan; Michael M Li; Stephen Y Kang; Sidharth V Puram
Journal:  Oral Oncol       Date:  2020-07-20       Impact factor: 5.337

4.  Comparative Evaluation of Immunohistochemical Expression of p16 with p16 Microsatellite Marker by PCR in Surgical Margins of Oral Squamous Cell Carcinoma.

Authors:  Deepa Babji; Ramakant Nayak; Kishore Bhat; Vijayalakshmi Kotrashetti; Jagadish Hosmani; Santosh Dindawar; Smita Pattanshetty
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-10-31

5.  Portrait of DNA methylated genes predictive of poor prognosis in head and neck cancer and the implication for targeted therapy.

Authors:  Jessica Hier; Olivia Vachon; Allison Bernstein; Iman Ibrahim; Alex Mlynarek; Michael Hier; Moulay A Alaoui-Jamali; Mariana Maschietto; Sabrina Daniela da Silva
Journal:  Sci Rep       Date:  2021-05-11       Impact factor: 4.379

6.  Methylation-mediated molecular dysregulation in clinical oral malignancy.

Authors:  Rebecca Towle; Cathie Garnis
Journal:  J Oncol       Date:  2012-05-07       Impact factor: 4.375

7.  Role of DNA methylation in head and neck cancer.

Authors:  Semra Demokan; Nejat Dalay
Journal:  Clin Epigenetics       Date:  2011-07-09       Impact factor: 6.551

8.  Nuclear heterogeneous nuclear ribonucleoprotein D is associated with poor prognosis and interactome analysis reveals its novel binding partners in oral cancer.

Authors:  Manish Kumar; Ajay Matta; Olena Masui; Gunjan Srivastava; Jatinder Kaur; Alok Thakar; Nootan Kumar Shukla; Ajoy RoyChoudhury; Meherchand Sharma; Paul G Walfish; K W Michael Siu; Shyam Singh Chauhan; Ranju Ralhan
Journal:  J Transl Med       Date:  2015-08-30       Impact factor: 5.531

Review 9.  p16INK4A and p14ARF gene promoter hypermethylation as prognostic biomarker in oral and oropharyngeal squamous cell carcinoma: a review.

Authors:  A Al-Kaabi; L W van Bockel; A J Pothen; S M Willems
Journal:  Dis Markers       Date:  2014-04-07       Impact factor: 3.434

10.  p16 (INK4a) has clinicopathological and prognostic impact on oropharynx and larynx squamous cell carcinoma.

Authors:  S D Silva; S Nonogaki; F A Soares; L P Kowalski
Journal:  Braz J Med Biol Res       Date:  2012-09-06       Impact factor: 2.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.